Homepage
Author:
SELLAS Life Sciences Group, Inc.
Posted Date:
May 14, 2026
SELLAS Life Sciences to Participate in Upcoming Investor Conferences
SELLAS Life Sciences Group, Inc.
May 14, 2026
SELLAS Life Sciences Reports First Quarter 2026 Financial Results and Provides Corporate Update
SELLAS Life Sciences Group, Inc.
May 12, 2026
SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update
SELLAS Life Sciences Group, Inc.
May 3, 2026
SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference
SELLAS Life Sciences Group, Inc.
May 2, 2026
SELLAS Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009
SELLAS Life Sciences Group, Inc.
May 2, 2026
